On Monday, Insmed Inc (NASDAQ: INSM) was -4.64% drop from the session before settling in for the closing price of $69.86. A 52-week range for INSM has been $21.92 – $80.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 22.42% over the past five years. When this article was written, the company’s average yearly earnings per share was at -0.69%. With a float of $174.61 million, this company’s outstanding shares have now reached $178.85 million.
Let’s look at the performance matrix of the company that is accounted for 912 employees. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Insmed Inc stocks. The insider ownership of Insmed Inc is 2.40%, while institutional ownership is 105.25%. The most recent insider transaction that took place on Jan 02 ’25, was worth 1,309,500. In this transaction Chair and CEO of this company sold 18,750 shares at a rate of $69.84, taking the stock ownership to the 384,960 shares. Before that another transaction happened on Jan 02 ’25, when Company’s Chair and CEO sold 6,830 for $69.86, making the entire transaction worth $477,144. This insider now owns 233,924 shares in total.
Insmed Inc (INSM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -0.69% per share during the next fiscal year.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
You can see what Insmed Inc (INSM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 34.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.18 in the next quarter and is forecasted to reach -4.34 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Insmed Inc (NASDAQ: INSM) saw its 5-day average volume 1.28 million, a negative change from its year-to-date volume of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 41.25%. Additionally, its Average True Range was 2.43.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 11.23%, which indicates a significant increase from 6.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.23% in the past 14 days, which was lower than the 37.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $71.50, while its 200-day Moving Average is $60.72. Nevertheless, the first resistance level for the watch stands at $69.23 in the near term. At $71.83, the stock is likely to face the second major resistance level. The third major resistance level sits at $73.43. If the price goes on to break the first support level at $65.03, it is likely to go to the next support level at $63.43. The third support level lies at $60.83 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
There are 178,903K outstanding shares of the company, which has a market capitalization of 11.90 billion. As of now, sales total 305,210 K while income totals -749,570 K. Its latest quarter income was 93,430 K while its last quarter net income were -220,520 K.
